← Back to Search

Deprescribing for Older Patients with Kidney Failure

N/A
Waitlist Available
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will help researchers understand if it is possible to reduce the number of medications prescribed to older adults receiving dialysis. The goal is to improve the safety and quality of life for this population.

Who is the study for?
This trial is for older adults who have been on dialysis for at least six months and are currently prescribed medication that may not be suitable, like opioids. It's not open to those who don't speak English, have advanced dementia, or are in hospice care.Check my eligibility
What is being tested?
The study is testing a deprescribing intervention tailored for older patients on dialysis. The goal is to see if it's possible to safely reduce medications that might cause more harm than good.See study design
What are the potential side effects?
Since the trial involves reducing certain medications, potential side effects could include withdrawal symptoms or the return of symptoms that were previously managed by these medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
number of potentially eligible subjects
proportion of deprescribing events
Secondary outcome measures
patient satisfaction as measured by interview

Trial Design

1Treatment groups
Experimental Treatment
Group I: Deprescribing InterventionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deprescribing Intervention
2019
N/A
~450

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,357 Previous Clinical Trials
3,419,040 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,693 Previous Clinical Trials
6,951,562 Total Patients Enrolled

Media Library

Deprescribing Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03631290 — N/A
Chronic Kidney Failure Research Study Groups: Deprescribing Intervention
Chronic Kidney Failure Clinical Trial 2023: Deprescribing Intervention Highlights & Side Effects. Trial Name: NCT03631290 — N/A
Deprescribing Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03631290 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment still have capacity for new participants?

"According to clinicaltrials.gov, this medical experiment is presently open for enrolment. It was initially listed on March 9th of 2022 and the details were most recently revised on March 14th of that same year."

Answered by AI

What is the uppermost capacity of subjects in this clinical trial?

"Affirmative. Clinicaltrials.gov attests that this research endeavour, which was first released on March 9th 2022 is presently seeking enrolment. A total of 40 participants must be recruited from 1 site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Deprescribing for Older Dialysis Patients
2022. "Deprescribing for Older Dialysis Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03631290.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top